DD
53
-6
BDX
56
10
TSCO
44
-4
ABT
59
2
MCO
71
-7
SRE
63
2
HAL
48
-3
RL
69
-4
PEG
62
4
AIV
64
4
TXT
53
-3
AA
56
15
PSA
56
3
LRCX
37
-9
DE
42
3
JBHT
56
-3
PCAR
56
-5
WYNN
36
-5
FRT
41
-2
GS
72
4
DD
53
-6
BDX
56
10
TSCO
44
-4
ABT
59
2
MCO
71
-7
SRE
63
2
HAL
48
-3
RL
69
-4
PEG
62
4
AIV
64
4
TXT
53
-3
AA
56
15
PSA
56
3
LRCX
37
-9
DE
42
3
JBHT
56
-3
PCAR
56
-5
WYNN
36
-5
FRT
41
-2
GS
72
4
Financhill
Back

Flaherty & Crumrine Total Return Fund Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
25

FLC
Flaherty & Crumrine Total Return Fund

Last Price:
16.60
Seasonality Move:
3.42%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
25
Flaherty & Crumrine Total Return Fund (FLC) is a Sell

Is Flaherty & Crumrine Total Return Fund a Buy, Sell or Hold?

  • The current Flaherty & Crumrine Total Return Fund [FLC] share price is $16.62. The Score for FLC is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • FLC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FLC Stock Price Chart

What is Flaherty & Crumrine Total Return Fund's stock price today?

  • The Flaherty & Crumrine Total Return Fund share price today is $16.62
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FLC is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

FLC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 36.19 Sell
Chaikin Money Flow: 2655 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.76 - 17.2) Sell
Bollinger Bands (100): (15.9 - 17.2) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

FLC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.85 Sell
20-day SMA: 16.92 Sell
50-day SMA: 17.1 Sell
200-day SMA: 15.84 Buy
8-day EMA: 16.79 Sell
20-day EMA: 16.91 Sell
50-day EMA: 16.89 Sell
200-day EMA: 16.05 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Flaherty & Crumrine Total Return Fund Earnings Growth & FLC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Flaherty & Crumrine Total Return Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):